ENGLISH ABSTRACT
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Portal vein involvement by hepatocellular carcinoma: diagnosis with three-dimensional contrast-enhanced MR angiography].

OBJECTIVE: To assess the accuracy of three-dimensional contrast-enhanced magnetic resonance angiography (3D CE MRA) in evaluating the portal vein involvement in patients with hepatocellular carcinoma.

METHODS: Ninety patients with hepatocellular carcinoma underwent 3D CE MRA of the portal venous system, using a high-field 1.5 T MR machine and a body coil and using Gd-DTPA as contrast material, before hepatic surgery or interventional therapy. The acquired source images of the examination were reconstructed into 3D MRA image similar to that of conventional X-ray angiography. The patency of the main, right and left portal veins was evaluated. A total of 270 veins were assessed. The patency was classified as normal or involved. The involvement included encasement, occlusion, and tumor thrombosis. The 3D CE MRA diagnoses were compared with the surgical-pathologic, intra-operative sonographic, and X-ray portographic findings.

RESULTS: 74 of the 75 involved portal veins and 188 of the 195 noninvolved portal veins confirmed by surgery or X-ray portography were detected by 3D CE MRA with an overall sensitivity rate of 99%, specificity rate of 96%, positive predictive value of 91%, and negative predictive value of 99%. The accuracy in diagnosis of the main portal vein was 100%. 3D CE MRA resulted in 7 false-positive interpretations involving 6 left portal veins and 1 right portal vein. One false-negative diagnosis was made on the right portal vein.

CONCLUSION: 3D CE MRA is quite accurate in evaluation of portal vein involvement in patients with hepatocellular carcinoma.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app